A 3′UTR Polymorphism Modulates mRNA Stability of the Oncogene and Drug Target Polo-Like Kinase 1

Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-13-87
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Stimulation of Polo-Like Kinase 3 mRNA Decay by Tristetraprolin

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2009English

Polo-Like Kinase-1 as a Novel Target in Neoplastic Mast Cells: Demonstration of Growth-Inhibitory Effects of Small Interfering RNA and the Polo-Like Kinase-1 Targeting Drug BI 2536

Haematologica
Hematology
2011English

Polo-Like Kinase 1 Is a Therapeutic Target in High-Risk Neuroblastoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

Polo-Like-Kinase 1: A Key Cellular Target for Anti-HBV Therapy?

Hepatology
MedicineHepatology
2017English

PLK1 (Polo-Like Kinase 1 (Drosophila))

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Polo-Like Kinase 1: A Novel Target for the Treatment of Therapy-Resistant Mantle Cell Lymphoma

Lymphoma
2013English

Polo-Like Kinase 1 Regulates the Stability of the Mitotic Centromere-Associated Kinesin in Mitosis

Oncotarget
Oncology
2014English

Regulating a Key Mitotic Regulator, Polo-Like Kinase 1 (PLK1)

Cytoskeleton
Cell BiologyStructural Biology
2018English

The Cell Cycle Kinase Polo Is Controlled by a Conserved 3′UTR Regulatory Sequence in Drosophila Melanogaster

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy